血浆支链/芳香族氨基酸、富含地中海饮食与2型糖尿病风险:PREDIMED试验中的病例队列研究
在PREDIMED试验嵌套的病例队列研究中,纳入251例新发2型糖尿病和694例随机样本。基线支链/芳香族氨基酸升高与2型糖尿病风险增加相关;1年内支链氨基酸评分升高仅在对照组与风险增加相关;富含特级初榨橄榄油的地中海饮食显著降低1年后支链氨基酸水平并减弱其与2型糖尿病发病的正相关。
要点
- 基线亮氨酸最高 vs 最低四分位与2型糖尿病风险 multivariable HR 3.29(95%CI 2.03, 5.34)。
- 1年内支链氨基酸评分每升高1个SD,对照组2型糖尿病风险 HR 1.61(95%CI 1.02, 2.54)。
- 地中海饮食+特级初榨橄榄油干预1年显著降低支链氨基酸水平(vs 对照组 p=0.005)。
核心结论
- 基线支链氨基酸较高及其1年内升高与2型糖尿病风险增加相关。
- 富含特级初榨橄榄油的地中海饮食显著降低支链氨基酸水平并减弱血浆支链氨基酸与2型糖尿病发病的正相关。
研究设计与样本
- PREDIMED试验嵌套的病例队列研究,纳入251例新发2型糖尿病和694例随机样本(641例无2型糖尿病及53例重叠病例)。
- 参与者随机分入地中海饮食+特级初榨橄榄油组(n=273)、地中海饮食+坚果组(n=324)或对照组(n=295)。
- 采用LC-MS/MS测定血浆氨基酸水平,2型糖尿病为PREDIMED试验预设的次要结局。
主要发现
- 中位随访3.8年,基线各支链/芳香族氨基酸最高 vs 最低四分位的多变量HR从苯丙氨酸1.32(95%CI 0.90, 1.92,趋势p=0.015)到亮氨酸3.29(95%CI 2.03, 5.34,趋势p<0.001)。
- 1年内支链氨基酸评分升高与2型糖尿病风险在对照组相关(每SD HR=1.61,95%CI 1.02, 2.54),在地中海饮食组不相关(交互作用p<0.001)。
- 地中海饮食+特级初榨橄榄油干预1年后显著降低支链氨基酸水平(vs 对照组 p=0.005)。
关键数值与推荐
- 基线亮氨酸最高 vs 最低四分位:多变量HR 3.29(95%CI 2.03, 5.34),趋势p<0.001。
- 基线苯丙氨酸最高 vs 最低四分位:多变量HR 1.32(95%CI 0.90, 1.92),趋势p=0.015。
- 对照组1年内支链氨基酸评分每升高1个SD:HR 1.61(95%CI 1.02, 2.54);地中海饮食组交互作用p<0.001。
- 地中海饮食+特级初榨橄榄油组 vs 对照组1年后支链氨基酸水平变化:p=0.005。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Branched-chain amino acids (BCAAs) and aromatic amino acids (AAAs) are associated with type 2 diabetes. However, repeated measurements of BCAA/AAA and their interactions with dietary interventions have not been evaluated. We investigated the associations between baseline and changes at 1 year in BCAA/AAA with type 2 diabetes in the context of a Mediterranean diet (MedDiet) trial. METHODS: We included 251 participants with incident type 2 diabetes and a random sample of 694 participants (641 participants without type 2 diabetes and 53 overlapping cases) in a case-cohort study nested within the PREvención con DIeta MEDiterránea (PREDIMED) trial. Participants were randomised to a MedDiet+extra-virgin olive oil (n = 273), a MedDiet+nuts (n = 324) or a control diet (n = 295). We used LC-MS/MS to measure plasma levels of amino acids. Type 2 diabetes was a pre-specified secondary outcome of the PREDIMED trial. RESULTS: Elevated plasma levels of individual BCAAs/AAAs were associated with higher type 2 diabetes risk after a median follow-up of 3.8 years: multivariable HR for the highest vs lowest quartile ranged from 1.32 for phenylalanine ([95% CI 0.90, 1.92], p for trend = 0.015) to 3.29 for leucine ([95% CI 2.03, 5.34], p for trend<0.001). Increases in BCAA score at 1 year were associated with higher type 2 diabetes risk in the control group with HR per SD = 1.61 (95% CI 1.02, 2.54), but not in the MedDiet groups (p for interaction <0.001). The MedDiet+extra-virgin olive oil significantly reduced BCAA levels after 1 year of intervention (p = 0.005 vs the control group). CONCLUSIONS/INTERPRETATION: Our results support that higher baseline BCAAs and their increases at 1 year were associated with higher type 2 diabetes risk. A Mediterranean diet rich in extra-virgin olive oil significantly reduced the levels of BCAA and attenuated the positive association between plasma BCAA levels and type 2 diabetes incidence. Clinical trial number: SRCTN35739639 ( www.controlled-trials.com ).
引用
- Ruiz-Canela M, Guasch-Ferré M, Toledo E, et al. Plasma branched chain/aromatic amino acids, enriched Mediterranean diet and risk of type 2 diabetes: case-cohort study within the PREDIMED Trial. Diabetologia. 2018. PMID: 29663011. doi:10.1007/s00125-018-4611-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。